Brief: Timber Pharmaceuticals - Qtrly Loss Per share $0.08
10/08/2021 14:57
Aug 10 (Reuters) - Timber Pharmaceuticals Inc TMBR.A :
* Q2 REVENUE $388,800
* QUARTERLY LOSS PER SHARE $0.08
Source text for Eikon: ID:nGNX8HDfsK
Further company coverage: TMBR.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trex Wind-Down
See all newsBrief: NYSE American To Suspend Trading Immediately In Timber Pharma
Brief: Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business
Brief: NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals
Brief: Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A "Stalking Horse" Asset Purchase Agreement
Brief: Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy - Court Filing